Ali Soleymannezhad

Ali Soleymannezhad

Former Chief Commercial OfficeratMaxcyte· In proxies 2024–2025

Pay in FY2025+11% from the year before · Maxcyte stock -62.7% the same year

Ali Soleymannezhad was paid $1.1M in FY2025 (Dec), up 11%. Maxcyte stock fell 62.7% that year.

Pay$100 in the stock at the end of FY23 → $33
Pay is from the Summary Compensation Table of each Maxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MaxcytePublic company · 2 yr
    • Former Chief Commercial Officer2024 – Present · 2 yrStock in role -62%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?